AGENAJEL for Pharma
.svg)
.svg)
Pregelatinized starches for smooth and creamy feel in pharmaceutical skin care
AGENAJEL For Pharma is a pharma-grade, waxy corn starch designed as a rheology modifier and thickening agent in topical pharmaceutical and dermo-cosmetic formulations. Its molecular structure yields controlled swelling and network formation in aqueous systems, supporting stable viscosity profiles and enhanced sensory properties in creams, lotions and gel vehicles intended for delivery of active ingredients.
Derived from waxy maize with functionalization tailored to pharmaceutical quality standards, AGENAJEL For Pharma enables consistent performance under the thermal and mechanical stresses typical of both cold- and hot-processed.
Key functions & benefits
- Consistent Rheological Control — Exhibits shear-thinning behavior with rapid viscosity recovery, facilitating spreadability while maintaining structure in finished formulations.
- Enhanced Sensory Texture — Contributes to a smooth, creamy feel with reduced greasiness on skin contact.
- Robust Processing Window — Demonstrates stability against varying pH, shear and temperature conditions, supporting manufacturing flexibility.
- Aqueous System Compatibility — Tailored for use in O/W emulsions, gels and lotions where controlled thickening and suspension of actives is required.
- Long Shelf Stability — Solid powder form with extended storage life under controlled humidity.
AGENAJEL For Pharma is suitable for thickening and structure modification in topical pharmaceutical formulations where consistent rheology supports dose uniformity and patient perceptibility.
Use in non-prescription skin care formulations such as moisturizers, barrier creams and therapeutic gels, to enhance texture and processing behavior.
Effective in cold- and hot-processed gel systems where clarity, body and tactile aesthetics are formulation priorities.
Product range
- INCI compliant for topical use
- Manufactured under quality systems suitable for pharmaceutical ingredient supply
- Microbiological specifications aligned with dermal pharmaceutical application expectations
*Conforms to the regulations of the European Pharmacopoeia (EUP) & the United States Pharmacopeia (USP), as amended.
Formulation guidance
- Disperse AGENAJEL For Pharma gradually into the aqueous phase under moderate agitation to avoid agglomeration.
- For cold-process gels, pre-suspend in glycerin or a portion of the internal phase to improve dispersion.
- Evaluate rheology in final product conditions; adjust concentration within typical formulation ranges to balance viscosity and sensory attributes.
Representative protocols and example formulations for creams, lotions and gels are available on request.
Packaging options
We offer a broad range of products and packaging solutions globally. Availability may vary by market due to local requirements. Please contact us to learn more about the options available in your region.